PTGS2 and neoplasm: Even more striking, it has been shown that structural analogs close to celecoxib, devoid of any COX-2 inhibitory activity, were able to mimic the anti-tumor properties of celecoxib studied so far, not only in vitro but also in various in vivo xenograft models (43, 50, 51).